Background: A number of studies reveal that home blood pressure variability is associated with cardiovascular risk factors. However, we do not have a consensus regarding the variability index and the frequency of measurements. Objective: The aim of the study was to assess home blood pressure variability for a period of 7 consecutive days and 24-hour ambulatory blood pressure variability using the average real variability index and to test whether home blood pressure variability represents a suitable parameter for long-term monitoring of the hypertensive patients. Material and methods: A number of 31 hypertensive patients were included in the study, 8 male, 23 female, mean age 60.19±7.35 years. At the inclusion ambulatory blood pressure monitoring was performed, home blood pressure monitoring was carried out for 7 consecutive days with 2 measurements daily. We compared ambulatory blood pressure values, variability using paired t-test. We were looking for correlations between HBP values and cardiovascular risk factors. Results: Ambulatory versus home blood pressure derived mean blood pressure was 131.38±15.2 versus 131.93±8.25, p=0.81. Ambulatory derived variability was 10.65±2.05 versus home variability 10.56±4.83, p=0.91. Home versus ambulatory pulse pressure was 51.8± 9.06 mmHg vs. 54.9±11.9 mmHg, p=0.046. We found positive correlation between HBPV and home BP values, p=0.027, r2=0.1577, (CI: 0.04967 to 0.6588). Home, as well as ambulatory derived variability were positively correlated to age p=0.043, r2=0.1377 (CI: 0.01234 to 0.6451) versus p<0.0001, CI: 0.3870 to 0.8220, r2=0.4302. Conclusion: Assessment of home blood pressure monitoring and variability could represent a well-tolerated alternative for long-term follow-up of hypertension management.
Introduction
The degree of blood pressure control is well highlighted by the SEPHAR II study, in which 59.1% of the hypertensive patients are treated and blood pressure control was recorded in only 25% of them [1] . Therefore, to increase treatment response and patient compliance, implementation of self-monitoring have to be encouraged. Although the 24-hour ambulatory monitoring of blood pressure represents the gold standard for the diagnosis and evaluation of treatment response in hypertension, home blood pressure measurement is widely available and well tolerated by the patient [2, 3] . Accumulating evidence reveals that an increase in 24-hour blood pressure variability as well as in home blood pressure variability is associated with end-organ damage [4] [5] [6] [7] . The self-measurement of blood pressure at home offers the possibility for a long-term monitoring of the blood pressure variability and removes the whitecoat phenomenon. It has been described that an increase in home blood pressure variability independent of mean blood pressure value, has a predictive value in the development of cardiac, vascular and renal damage [8] . Until now, there is a great diversity among studies regarding protocols including duration of monitoring, number of measurements as well as the use of a reliable parameter to assess home blood pressure variability [9] . Despite of available data regarding the relationship of ambulatory and home blood pressure variability with end-organ damage and cardiovascular mortality, there is a lack of studies comparing the utility of home versus ambulatory variability of blood pressure. Therefore, the aim of the present study was to assess home blood pressure variability for a period of 7 consecutive days and 24-hour ambulatory blood pressure variability, using the average real variability index and to test whether home blood pressure variability represents a suitable parameter for long-term follow-up of the hypertensive patients.
Methods
This observational study was performed in County Clinical Hospital Targu-Mures, department for Internal Medicine IV and included 31 hypertensive patients, 8 males and 23 females, mean age was 60.19±7.35 years. All subjects gave written informed consent and the study was approved by Local Ethical Committee according to the International Ethical Guidelines and Declaration of Helsinki. Inclusion criteria were: history of hypertension, use of antihypertensive medication. Exclusion criteria were: patients with arrhythmias, congestive heart failure NYHA class III/IV, coagulation disease, non-cooperative patients.
Twenty four-hour ambulatory BP monitoring was performed with a validated device (ABPM 05®, Meditech Ltd., Hungary) applied on the non-dominant arm of the patients. Measurements started between 8-10 am, the frequency of the blood pressure measurements was set at 20 minutes daytime and nighttime. After 24-hour blood pressure recording, home blood pressure monitoring was performed with validated semi-automated oscillometric devices according to ESC practical aspects and ESH practical guidelines on home blood pressure monitoring. Patients were trained how to perform correct measurements. A 24 cm standard cuff was placed approximately 2-3 cm above the bend of the elbow. Duplicate measurements were performed, each about 1-2 minutes apart, in the morning before drug intake and evening before meal, for a period of 7 consecutive days, prior to the one month visit. Measurements were performed in a quiet room with the patients seated comfortably for at least 5 minutes with the arm resting on a table and the cuff at heart level [10, 11] . The results were noted in a logbook after each measurement. Average blood pressure was calculated after excluding the values of the first monitoring day. Ambulatory as well as home blood pressure variability were calculated according to the formula of average real variability (ARV) using a computerized program [12] . Ambulatory blood pressure data like mean daytime, nighttime and 24-hour BP, pulse pressure, morning surge, diurnal/nocturnal index were obtained automatically from the measurement device. Home monitoring derived mean systolic/diastolic blood pressure, home variability and pulse pressure were calculated in MS Excel program. Demographic characteristics (age, gender, high, weight), the treatment regimen of each patient were collected in a questionnaire. Data were collected as raw data, using MS Excel program, statistical analysis were performed using Graph Pad Prism version 5 statistical software. Numerical data are represented as mean±SD. Means were compared using paired t-test, correlations were calculated with Pearson's correlation test for data representing Gaussian distribution. A p value ≤ 0.05 was considered statistically significant with a confidence interval set at 95%.
Results
A number of 31 treated hypertensive patients were included in the study, 8 male and 23 female, mean age was 60.19±7.35 years. Body mass index was 30±2.46 kg/m 2 , there were 11 dippers and 20 non-dippers. Regarding laboratory parameters: mean cholesterol level was 204.4±24.7 mg/dl, triglycerides were 186.1±78.9. Mean systolic blood pressure measured by ambulatory and home monitoring were almost equal (figure 1). Blood pressure variability determined by average real variability showed no significant difference at ABPM versus HBPM (figure 2). Ambulatory monitoring derived diastolic blood pressure was statistically significant lower compared to home monitoring diastolic blood pressure, 76.6±6.2 mmHg versus 83.7±6 mmHg, p<0.0001. Ambulatory monitoring derived pulse pressure was significantly higher compared to home monitoring derived pulse pressure, 54.9±11.9 versus 51.8±9.06, p=0.046. Home and ambulatory blood pressure variability were positively correlated to age p=0.043, r2=0.1377 (CI: 0.01234 to 0.6451) versus p<0.0001, CI: 0.3870 to 0.8220, r2=0.4302.
We found positive correlation between 24-hour systolic blood pressure and its variability defined with average real variability, p=0.013, r 2 =0.2001, CI: 0.1037 to 0.6956. This correlation was observed also between home measured systolic blood pressure values and blood pressure variability calculated for at least 14 measurements, p= 0.027, r 2 =0.1577, CI: 0.04967 to 0.6588 ( figure 3 ). Home variability was positively correlated to home pulse pressure, p<0.0001, r 2 = 0.4102, CI: 0.3700 to 0.8108.
Discussion
An increasing number of studies investigating the relationship between home blood pressure variability with cardiovascular risk factors found that female gender, advanced age, increased mean blood pressure, smoking as well as other factors are associated with increased HBPV [13, 14] . Evidence is available that an increased day-by-day variability assessed by home monitoring, independently of average home blood pressure levels, is a predictor of development and progression of end-organ damage [15] . In the FinnHome study, increased home blood pressure variability performed over seven consecutive days was associated with a higher risk of cardiovascular events after a period of 7.8 years of follow-up [16] . In contrast to the mentioned study, we compared ambulatory and home blood pressure values as well as variability and investigated the relationship between blood pressure monitoring derived parameters and variability in a high-risk population defined by elevated total serum cholesterol and triglyceride levels as well as age. We found that ambulatory and home monitoring derived mean systolic blood pressure and variability defined as average real variability were almost equal. Ambulatory monitoring derived mean diastolic blood pressure was greater than the home measured. Therefore, ambulatory pulse pressure was higher than home monitoring derived pulse pressure. A possible explanation could be that blood pressure fluctuation is a complex phenomenon influenced by arterial compliance, humoral factors, and behavioral changes [17] . Ambulatory as well as home monitoring derived variability defined as average real variability, showed positive correlation with mean systolic blood pressure levels. It is known, that ambulatory blood pressure variability correlates with arterial stiffness defined by pulse pressure [18] . Based on our findings, this observation is also available for home blood pressure variability which showed positive correlation with home measured pulse pressure.
Self-measurement of blood pressure is a comfortable and cheap method and it represents an appropriate method for long-term follow-up of treated patients, but ABPM and HBPM provide complementary information, therefore in clinical practice, the appropriate combination of this methods is required [19] .
Therefore, home blood pressure monitoring performed for at least 7 consecutive days, prior to programmed doctor visit and the assessment of home variability using the average real variability formula, could represent a welltolerated and cost-efficient method in terms of long-term follow-up of the hypertensive patient [20] .
Conclusion
Although the 24-hour blood pressure monitoring remains the gold standard in terms of long-term follow-up of hypertension management, self-measurement of the blood pressure and calculation of its variability represents a complementary method for long-term follow-up, and is accepted by the patients. In treated hypertensive patients with optimal controlled blood pressure values at ambulatory monitoring, if at one month follow-up, home variability values are close to the ambulatory ARV values, it might be used as a measure of visit-to-visit blood pressure control, below obtaining optimal blood pressure values, but future studies are needed to define a universally accepted index and an optimal self-monitoring schedule.
